Grace E Nipp, Richmond Woodward, Andrew Gross, Jordan Deaner, Dilraj S Grewal
{"title":"僵人综合征自身免疫性视网膜病变的演变:病例报告","authors":"Grace E Nipp, Richmond Woodward, Andrew Gross, Jordan Deaner, Dilraj S Grewal","doi":"10.1097/ICB.0000000000001580","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The aim of this study was to report a case of autoimmune retinopathy as the presenting feature of stiff person syndrome and assess its evolution.</p><p><strong>Methods: </strong>Case report.</p><p><strong>Results: </strong>A 35-year-old man presented with progressive, chronic vision loss. On initial examination, visual acuity measured 20/20 in the right eye and 20/50 left eye. Humphrey Visual Field testing demonstrated decreased foveal threshold in both eyes. Mild subfoveal ellipsoid zone loss was noted on optical coherence tomography. Five years later, the patient presented with painful lower extremity muscle spasms and stiffness and complained of increasing vision loss with difficulty distinguishing colors. Optical coherence tomography showed marked progression of ellipsoid zone loss. Scotoma was demonstrated on Humphrey visual field, and electroretinography demonstrated reduced responses consistent with bilateral severe maculopathy. Serum testing showed autoantibodies to the glutamic acid decarboxylase 65-kDa isoform (GAD65) at a high titer and a diagnosis of autoimmune retinopathy in the setting of stiff person syndrome was made. A systemic workup for malignancy was negative. The patient was treated with IV immune globulin and transitioned to rituximab with improvement in systemic symptoms.</p><p><strong>Conclusion: </strong>Unlike previous cases of autoimmune retinopathy in the setting of stiff person syndrome, vision symptoms and optical coherence tomography changes presented years before the onset of muscle spasms. Etiologies such as SPS should be on the differential of unexplained retinopathy, even in the absence of systemic symptoms, especially when paraneoplastic etiologies are ruled out.</p>","PeriodicalId":53580,"journal":{"name":"Retinal Cases and Brief Reports","volume":" ","pages":"297-303"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"EVOLUTION OF AUTOIMMUNE RETINOPATHY IN STIFF PERSON SYNDROME: A CASE REPORT.\",\"authors\":\"Grace E Nipp, Richmond Woodward, Andrew Gross, Jordan Deaner, Dilraj S Grewal\",\"doi\":\"10.1097/ICB.0000000000001580\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>The aim of this study was to report a case of autoimmune retinopathy as the presenting feature of stiff person syndrome and assess its evolution.</p><p><strong>Methods: </strong>Case report.</p><p><strong>Results: </strong>A 35-year-old man presented with progressive, chronic vision loss. On initial examination, visual acuity measured 20/20 in the right eye and 20/50 left eye. Humphrey Visual Field testing demonstrated decreased foveal threshold in both eyes. Mild subfoveal ellipsoid zone loss was noted on optical coherence tomography. Five years later, the patient presented with painful lower extremity muscle spasms and stiffness and complained of increasing vision loss with difficulty distinguishing colors. Optical coherence tomography showed marked progression of ellipsoid zone loss. Scotoma was demonstrated on Humphrey visual field, and electroretinography demonstrated reduced responses consistent with bilateral severe maculopathy. Serum testing showed autoantibodies to the glutamic acid decarboxylase 65-kDa isoform (GAD65) at a high titer and a diagnosis of autoimmune retinopathy in the setting of stiff person syndrome was made. A systemic workup for malignancy was negative. The patient was treated with IV immune globulin and transitioned to rituximab with improvement in systemic symptoms.</p><p><strong>Conclusion: </strong>Unlike previous cases of autoimmune retinopathy in the setting of stiff person syndrome, vision symptoms and optical coherence tomography changes presented years before the onset of muscle spasms. Etiologies such as SPS should be on the differential of unexplained retinopathy, even in the absence of systemic symptoms, especially when paraneoplastic etiologies are ruled out.</p>\",\"PeriodicalId\":53580,\"journal\":{\"name\":\"Retinal Cases and Brief Reports\",\"volume\":\" \",\"pages\":\"297-303\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Retinal Cases and Brief Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/ICB.0000000000001580\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Retinal Cases and Brief Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/ICB.0000000000001580","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
目的:报告一例以自身免疫性视网膜病变(AIR)为主要特征的僵人综合征(SPS)病例,并评估其演变情况:一名 35 岁的男子出现了进行性、慢性视力下降。初次检查时,视力为外方20/20,内方20/50。汉弗莱视野测试(HVF)显示,OU 眼窝阈值下降。光学相干断层扫描(OCT)发现轻微的眼窝下椭圆形区缺损。五年后,患者出现下肢肌肉痉挛和僵硬疼痛,并主诉视力日益下降,难以分辨颜色。光学相干断层扫描(OCT)显示,椭圆形区缺损明显加重。HVF显示有视网膜瘤,视网膜电图显示反应减弱,与双侧严重黄斑病变一致。血清检测显示,谷氨酸脱羧酶65-千道尔顿同工酶(GAD65)的自身抗体滴度很高,诊断为SPS情况下的AIR。全身恶性肿瘤检查结果为阴性。患者接受了 IVIG 治疗,随后转用利妥昔单抗,全身症状有所改善:与以往在 SPS 情况下出现 AIR 的病例不同,该患者在肌肉痉挛发作前数年就出现了视力症状和 OCT 变化。即使没有全身症状,特别是在排除了副肿瘤病因的情况下,不明原因视网膜病变的鉴别中也应包括SPS等病因。
EVOLUTION OF AUTOIMMUNE RETINOPATHY IN STIFF PERSON SYNDROME: A CASE REPORT.
Purpose: The aim of this study was to report a case of autoimmune retinopathy as the presenting feature of stiff person syndrome and assess its evolution.
Methods: Case report.
Results: A 35-year-old man presented with progressive, chronic vision loss. On initial examination, visual acuity measured 20/20 in the right eye and 20/50 left eye. Humphrey Visual Field testing demonstrated decreased foveal threshold in both eyes. Mild subfoveal ellipsoid zone loss was noted on optical coherence tomography. Five years later, the patient presented with painful lower extremity muscle spasms and stiffness and complained of increasing vision loss with difficulty distinguishing colors. Optical coherence tomography showed marked progression of ellipsoid zone loss. Scotoma was demonstrated on Humphrey visual field, and electroretinography demonstrated reduced responses consistent with bilateral severe maculopathy. Serum testing showed autoantibodies to the glutamic acid decarboxylase 65-kDa isoform (GAD65) at a high titer and a diagnosis of autoimmune retinopathy in the setting of stiff person syndrome was made. A systemic workup for malignancy was negative. The patient was treated with IV immune globulin and transitioned to rituximab with improvement in systemic symptoms.
Conclusion: Unlike previous cases of autoimmune retinopathy in the setting of stiff person syndrome, vision symptoms and optical coherence tomography changes presented years before the onset of muscle spasms. Etiologies such as SPS should be on the differential of unexplained retinopathy, even in the absence of systemic symptoms, especially when paraneoplastic etiologies are ruled out.